Epidemiology — MCQs

Epidemiology Indian Medical PG Practice Questions and MCQs

Question 501: What type of study is a cohort study?

A. Descriptive observational
B. Analytic observational (Correct Answer)
C. Experimental
D. Controlled trial

Explanation: ### Explanation **1. Why "Analytic Observational" is Correct:** Epidemiological studies are broadly classified into **Observational** and **Experimental**. In observational studies, the investigator does not intervene but merely observes the natural course of events. * **Observational studies** are further divided into **Descriptive** (generating hypotheses) and **Analytic** (testing hypotheses). * A **Cohort study** is an **Analytic Observational** study because it tests a specific hypothesis by comparing an "exposed" group to a "non-exposed" group to determine the association between a risk factor and an outcome. It proceeds from cause to effect (prospective). **2. Why Other Options are Incorrect:** * **A. Descriptive observational:** These studies (e.g., Case reports, Case series, Cross-sectional surveys) only describe the distribution of disease by time, place, and person. They do not use a comparison group to test associations. * **C. Experimental:** In experimental studies (e.g., RCTs), the investigator actively manipulates the exposure (the "intervention") through randomization. In a cohort study, the exposure is naturally occurring. * **D. Controlled trial:** This is a subtype of experimental study. While a cohort study has a "control" (unexposed) group, it lacks the deliberate intervention and randomization characteristic of a trial. **3. NEET-PG Clinical Pearls:** * **Directionality:** Cohort studies are typically **prospective** (Forward-looking: Exposure $\rightarrow$ Outcome). * **Measure of Association:** The key parameter calculated is **Relative Risk (RR)** and **Attributable Risk (AR)**. * **Indications:** Best for studying **rare exposures** (not rare diseases; for rare diseases, use Case-Control). * **Incidence:** Cohort studies are the only observational study design that can directly calculate the **Incidence** of a disease. * **Mnemonic:** "COHORT" – **C**ause to **O**utcome; **H**ighly expensive; **O**bservational; **R**isk **T**racking.

Question 502: Physicians likely have a higher index of suspicion for tuberculosis in children without a BCG scar compared to those with a BCG scar. If an association is found between tuberculosis and not having a BCG scar, what type of bias could explain this association?

A. Selection bias
B. Interviewer bias (Correct Answer)
C. Surveillance bias
D. Non-response bias

Explanation: ### Explanation **Why Interviewer Bias is Correct:** Interviewer bias (also known as observer bias) occurs when the researcher’s prior knowledge or expectations influence how they collect, record, or interpret data. In this scenario, the physician (the interviewer/observer) has a **higher index of suspicion** for tuberculosis (TB) in children without a BCG scar. Because they expect these children to be at higher risk, they may probe more deeply for symptoms, order more diagnostic tests, or interpret borderline clinical findings as positive for TB. This systematic difference in the evaluation process leads to an artificial association between the lack of a BCG scar and the diagnosis of TB. **Analysis of Incorrect Options:** * **Selection Bias:** This occurs when the study population is not representative of the target population due to the way subjects are recruited (e.g., Berkson’s bias). Here, the bias arises during the *assessment* phase, not the *selection* phase. * **Surveillance Bias (Detection Bias):** While similar, this specifically refers to one group being followed more closely or screened more frequently than another. While the physician is "suspicious," the core issue described is the subjective influence on the diagnostic process (Interviewer/Observer bias). *Note: In many textbooks, Surveillance Bias is considered a subtype of Selection or Information bias; however, "Interviewer Bias" most accurately captures the physician's subjective influence.* * **Non-response Bias:** This occurs when individuals who refuse to participate in a study differ significantly from those who do participate. **NEET-PG High-Yield Pearls:** * **Interviewer Bias** can be minimized by **blinding** the observer to the exposure status of the subject. * **Recall Bias** is a common type of information bias in case-control studies where cases remember past exposures more accurately than controls. * **Berkson’s Bias** is a selection bias occurring when hospital-based cases and controls are used. * **Hawthorne Effect** is the tendency of study subjects to change their behavior because they know they are being observed.

Question 503: Which of the following conditions typically exhibits a bimodal distribution?

A. Thyroid carcinoma
B. Hodgkin's lymphoma (Correct Answer)
C. Renal carcinoma
D. Liver carcinoma

Explanation: ### Explanation **Correct Option: B. Hodgkin's lymphoma** In epidemiology, a **bimodal distribution** occurs when a disease exhibits two distinct peaks of incidence across different age groups. Hodgkin’s Lymphoma (HL) is the classic textbook example of this phenomenon. * **First Peak:** Occurs in young adults, typically between the ages of **15 and 35 years**. * **Second Peak:** Occurs in older adults, usually **after the age of 50–55 years**. The underlying etiology is believed to differ between these peaks; the first is often associated with socio-economic factors and Epstein-Barr Virus (EBV) in certain subtypes, while the second is more related to age-associated immune senescence. **Analysis of Incorrect Options:** * **A. Thyroid Carcinoma:** Generally shows a progressive increase in incidence with age, though Papillary Thyroid Cancer is common in middle-aged females. It does not follow a classic bimodal pattern. * **C. Renal Carcinoma:** Primarily a disease of the elderly, with peak incidence occurring between **60 and 70 years**. * **D. Liver Carcinoma (HCC):** Incidence typically rises steadily with age, often peaking in the **6th decade**, strongly linked to chronic Hepatitis B/C or cirrhosis. **High-Yield Clinical Pearls for NEET-PG:** * **Other Bimodal Diseases:** Besides Hodgkin's, other conditions showing bimodal peaks include **Acute Lymphoblastic Leukemia (ALL)** (peaks at age 2–5 and again in the elderly) and **Atopic Dermatitis**. * **Reed-Sternberg Cells:** The pathological hallmark of Hodgkin's Lymphoma ("Owl-eye appearance"). * **Epidemiological Curves:** A bimodal curve suggests that the population consists of two different groups with different levels of risk or different causative mechanisms.

Question 504: Japanese encephalitis is caused by which genus of mosquito?

A. Culex (Correct Answer)
B. Aedes
C. Mansonia
D. Anopheles

Explanation: **Explanation:** **Japanese Encephalitis (JE)** is a viral zoonotic disease caused by the JE virus (a Flavivirus). The primary vector for this disease is the **Culex** mosquito, specifically the species **Culex tritaeniorhynchus**. These mosquitoes are "paddy-field breeders," and the transmission cycle involves pigs (amplifying hosts) and water birds (reservoirs). **Analysis of Options:** * **A. Culex (Correct):** *Culex tritaeniorhynchus* is the principal vector in India. They are persistent night-biters and prefer outdoor resting (exophilic). * **B. Aedes:** This genus is primarily responsible for transmitting **Dengue, Chikungunya, Zika, and Yellow Fever**. *Aedes aegypti* is a day-biter and breeds in artificial containers. * **C. Mansonia:** These mosquitoes are the primary vectors for **Brugian Filariasis** (*Brugia malayi*). They are unique because their larvae attach to the roots of aquatic plants (e.g., *Pistia*) for respiration. * **D. Anopheles:** This genus is the well-known vector for **Malaria**. In India, *Anopheles stephensi* (urban) and *Anopheles culicifacies* (rural) are the major species. **High-Yield NEET-PG Pearls:** * **Amplifying Host:** Pigs are the most important amplifying hosts for JE (they develop high viremia without getting sick). * **Incidental/Dead-end Hosts:** Humans and horses (viremia is too low to infect mosquitoes). * **Vaccination:** The **SA-14-14-2** (live attenuated) vaccine is used under the Universal Immunization Programme (UIP) in endemic districts of India. * **Control:** The most effective environmental measure is "Water Management" in rice fields (Intermittent Irrigation).

Question 505: What is the definition of prevalence?

A. Rate
B. Ratio
C. Proportion (Correct Answer)
D. Mean

Explanation: **Explanation:** Prevalence is defined as the total number of all individuals (both old and new cases) who have a specific disease or condition at a particular point in time (or over a specified period) divided by the total population at risk. **Why Proportion is Correct:** In epidemiology, a **proportion** is a type of ratio where the numerator is always included in the denominator (A / A+B). Since the individuals with the disease (numerator) are part of the total population being studied (denominator), prevalence is expressed as a proportion (usually as a percentage). It describes the "burden of disease" in a population. **Why Other Options are Incorrect:** * **Rate:** A rate measures the speed at which an event occurs and includes **time** in the denominator (e.g., Incidence Rate). Prevalence does not measure the speed of new cases; it is a static "snapshot." * **Ratio:** While all proportions are ratios, a "Ratio" specifically refers to the relation between two independent quantities where the numerator is *not* part of the denominator (e.g., Male:Female ratio). * **Mean:** This is a measure of central tendency (average) and does not describe the frequency of disease occurrence in a population. **High-Yield Clinical Pearls for NEET-PG:** * **Formula:** Prevalence = Incidence × Mean Duration of Disease ($P = I \times D$). * **Incidence** is a **Rate** (measures new cases only). * **Prevalence** is a **Proportion** (measures all existing cases). * Prevalence is increased by: Longer duration of illness, prolongation of life without a cure, and in-migration of cases. * Prevalence is decreased by: High fatality rate, shorter duration of disease, and improved cure rates.

Question 506: What is the predictive value of a positive test?

A. True positive / (True positive + False positive) x 100
B. True positive / (True positive + False positive) x 100 (Correct Answer)
C. False positive / (True positive + False positive) x 100
D. False positive / (True positive + False positive) x 100

Explanation: **Explanation:** **Positive Predictive Value (PPV)** is a measure of a diagnostic test's precision. It answers the clinical question: *"If a patient tests positive, what is the probability that they actually have the disease?"* 1. **Why Option B is Correct:** The formula for PPV is the ratio of **True Positives (TP)** to the **Total Number of Positive Tests** (which includes both True Positives and False Positives). * **Formula:** $PPV = \frac{TP}{TP + FP} \times 100$ This correctly identifies the proportion of "test-positive" individuals who are truly diseased. 2. **Why Other Options are Incorrect:** * **Options C and D:** These represent the "False Discovery Rate" or the proportion of errors among positive results. They do not reflect the predictive accuracy for the presence of disease. * **Note on Sensitivity:** Do not confuse PPV with **Sensitivity**. Sensitivity is $\frac{TP}{TP + FN}$, which measures how well the test identifies diseased individuals from the *total diseased population*, whereas PPV measures accuracy among those the *test labeled as positive*. 3. **High-Yield Clinical Pearls for NEET-PG:** * **Prevalence Dependency:** Unlike Sensitivity and Specificity (which are inherent to the test), PPV is **directly proportional to the prevalence** of the disease in the population. If prevalence increases, PPV increases. * **Screening Utility:** In clinical practice, PPV is more useful than sensitivity for a clinician when interpreting a lab report for an individual patient. * **Negative Predictive Value (NPV):** The counterpart is $NPV = \frac{TN}{TN + FN} \times 100$, which measures the probability that a person with a negative test is truly disease-free.

Question 507: Which of the following best defines "incidence"?

A. The number of new cases of a disease occurring in a defined population during a specified period.
B. The total number of existing cases (new and old) of a disease in a defined population at a particular point in time.
C. The proportion of individuals in a population who are susceptible to a disease.
D. None of the above (Correct Answer)

Explanation: **Explanation:** The correct answer is **None of the above** because the options provided fail to include the essential mathematical component of a **Rate**. **1. Why "None of the above" is correct:** Incidence is defined as the number of **new cases** occurring in a defined population during a specific period of time **per 1,000 (or other multiplier) population at risk**. Option A describes the *numerator* of the incidence formula but omits the *denominator* (population at risk). Without the denominator, it is merely a "count," not a "rate." Incidence is a true rate as it includes the dimension of time. **2. Analysis of Incorrect Options:** * **Option A:** This is the **Incidence Number** (count), not the Incidence Rate. A rate must express the relationship between the new cases and the population at risk. * **Option B:** This is the definition of **Point Prevalence**. Prevalence measures the total burden of disease (new + old cases) at a specific moment, whereas incidence measures the "flow" or "attack" of the disease. * **Option C:** This refers to the **Susceptible Pool**, which is used to determine the denominator for calculating incidence, but it does not define incidence itself. **3. NEET-PG High-Yield Pearls:** * **Formula:** $\text{Incidence} = \frac{\text{Number of new cases of specific disease during a given time period}}{\text{Population at risk during that period}} \times 1000$ * **Key Distinction:** Incidence = **New** cases (Rate); Prevalence = **All** cases (Ratio). * **Relationship:** $\text{Prevalence (P)} = \text{Incidence (I)} \times \text{Mean Duration of disease (D)}$. * **Utility:** Incidence is the best indicator for measuring the **efficacy of preventive programs** and determining the **etiology/risk** of acute diseases.

Question 508: Which of the following best defines a carrier in the context of infectious diseases?

A. A person, animal, or object from which an infectious agent passes to a susceptible host.
B. A person, animal, or object in which an infectious agent lives and multiplies.
C. An infected person harboring an infectious agent without clinical features, acting as a source of infection. (Correct Answer)
D. A person in whom an infectious agent lies dormant.

Explanation: ### Explanation **Correct Answer: C** In epidemiology, a **carrier** is defined by three essential criteria: 1. The presence of a specific infectious agent in the body. 2. The **absence of recognizable clinical signs and symptoms** (subclinical or asymptomatic state). 3. The ability to shed the agent, thereby acting as a **source of infection** to others. Carriers are epidemiologically dangerous because they continue their normal activities, unknowingly spreading the disease, unlike "cases" who are often restricted by illness. **Analysis of Incorrect Options:** * **Option A (Source):** This describes the **Source of Infection**. While a carrier can be a source, this definition is too broad as it includes inanimate objects (fomites) and the immediate point from which the agent passes to the host. * **Option B (Reservoir):** This is the definition of a **Reservoir**. A reservoir is the natural habitat (man, animal, or environmental medium) where an agent lives and multiplies, and upon which it primarily depends for survival. * **Option C (Latent Infection):** This describes **Latent Infection**. In latency, the host is infected, but the agent is "dormant" and typically **not being shed**. A carrier, by definition, must be capable of shedding the agent. **High-Yield Clinical Pearls for NEET-PG:** * **Typhoid Mary:** The most famous example of a chronic carrier (Gallbladder is the site of colonization). * **Pseudo-carrier:** A term sometimes used for those who shed agents that are not primary pathogens. * **Classification:** Carriers are classified by **Type** (Incubatory, Convalescent, Healthy) and **Duration** (Temporary vs. Chronic). * **Chronic Carrier:** One who sheds the agent for more than 3 months (e.g., Hepatitis B, Typhoid). * **Incubatory Carrier:** Sheds the agent during the incubation period (e.g., Measles, Mumps, Polio).

Question 509: Trachoma screening is performed on which of the following age groups?

A. Less than 5 years
B. 5-10 years
C. 1-9 years (Correct Answer)
D. 5-15 years

Explanation: **Explanation:** The correct answer is **1-9 years (Option C)**. This is based on the World Health Organization (WHO) guidelines for the elimination of Trachoma as a public health problem. **1. Why 1-9 years is correct:** Active Trachoma (characterized by follicular inflammation, or **TF**) is primarily a disease of childhood. The WHO uses the prevalence of **Trachoma Inflammation—Follicular (TF)** in children aged **1 to 9 years** as the key indicator to determine if a district requires mass drug administration (MDA) or if the disease has been eliminated. If the prevalence of TF in this age group is $\geq 5\%$, the SAFE strategy (Surgery, Antibiotics, Facial cleanliness, Environmental improvement) is implemented. **2. Why other options are incorrect:** * **Less than 5 years (Option A):** While children under 5 are highly susceptible, this range misses the older cohort (5-9 years) who still harbor significant infection and contribute to community transmission. * **5-10 years (Option B) & 5-15 years (Option D):** These ranges exclude toddlers (1-4 years), who often have the highest bacterial loads and are the primary reservoir for *Chlamydia trachomatis*. **3. High-Yield Clinical Pearls for NEET-PG:** * **SAFE Strategy:** **S**urgery (for Trichiasis), **A**ntibiotics (Azithromycin), **F**acial cleanliness, **E**nvironmental improvement. * **Drug of Choice:** A single dose of **Azithromycin (20 mg/kg)** is the mainstay of the 'A' in SAFE. * **Elimination Threshold:** Trachoma is considered eliminated as a public health problem when TF prevalence is **< 5%** in children aged 1–9 years and the Trachomatous Trichiasis (TT) rate is **< 0.2%** in adults over 15 years. * **India Status:** India was declared free from "Infective Trachoma" by the WHO in 2017, but surveillance continues in endemic pockets.

Question 510: A test has a sensitivity of 90% and a specificity of 95%. Which of the following statements is true?

A. The test is likely to be useful for general screening.
B. Sensitivity equals the true positive rate (true positive / (true positive + false negative)). (Correct Answer)
C. Sensitivity indicates that the test is negative when the disease is present.
D. 10% of positive tests are false positives.

Explanation: ### Explanation **1. Why Option B is Correct:** Sensitivity is defined as the ability of a test to correctly identify those with the disease. Mathematically, it is the **True Positive Rate (TPR)**. The formula is: $$\text{Sensitivity} = \frac{\text{True Positives (TP)}}{\text{True Positives (TP)} + \text{False Negatives (FN)}}$$ The denominator (TP + FN) represents the total number of individuals who actually have the disease. Therefore, Option B is a direct and accurate definition of the term. **2. Why Other Options are Incorrect:** * **Option A:** While 90% sensitivity is good, "general screening" tests ideally require very high sensitivity (often >95-99%) to ensure no cases are missed. However, Option B is a mathematical fact, making it the "most" correct answer. * **Option C:** This is the definition of a **False Negative**. Sensitivity actually indicates that the test is *positive* when the disease is *present*. * **Option D:** This is a common trap. If sensitivity is 90%, then 10% of diseased people will test negative (**False Negative Rate**). The percentage of positive tests that are false positives is determined by the **Positive Predictive Value (PPV)**, which depends on the prevalence of the disease in the population, not just the test's sensitivity. **3. NEET-PG High-Yield Clinical Pearls:** * **SNOUT:** **S**ensitivity rules **OUT** (High sensitivity means a negative result reliably rules out the disease). * **SPIN:** **S**pecificity rules **IN** (High specificity means a positive result reliably rules in the disease). * **Complementary Values:** * False Negative Rate = $1 - \text{Sensitivity}$ * False Positive Rate = $1 - \text{Specificity}$ * **Prevalence Impact:** Predictive values (PPV/NPV) change with disease prevalence, but Sensitivity and Specificity are inherent properties of the test and remain constant.

Practice by Chapter

Principles of Epidemiology

Practice Questions

Measures of Disease Frequency

Practice Questions

Epidemiological Study Designs

Practice Questions

Descriptive Epidemiology

Practice Questions

Analytical Epidemiology

Practice Questions

Experimental Epidemiology

Practice Questions

Screening for Disease

Practice Questions

Surveillance Systems

Practice Questions

Investigation of an Epidemic

Practice Questions

Association and Causation

Practice Questions

Modern Epidemiological Methods

Practice Questions

Critical Appraisal of Epidemiological Studies

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free